Cita APA

Chasen, M., Urban, L., Schnadig, I., Rapoport, B., Powers, D., Arora, S., . . . Gridelli, C. (2016). Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy. Support Care Cancer.

Chicago Style Citation

Chasen, Martin, Laszlo Urban, Ian Schnadig, Bernardo Rapoport, Dan Powers, Sujata Arora, Rudolph Navari, Lee Schwartzberg, i Cesare Gridelli. "Rolapitant Improves Quality of Life of Patients Receiving Highly or Moderately Emetogenic Chemotherapy." Support Care Cancer 2016.

Cita MLA

Chasen, Martin, et al. "Rolapitant Improves Quality of Life of Patients Receiving Highly or Moderately Emetogenic Chemotherapy." Support Care Cancer 2016.